Monsanto and Dow AgroSciences Announce Global Licensing Agreement on Exzact Precision Technology Genome-Editing Platform
Dow AgroSciences | October 03, 2016
Monsanto Company (NYSE: MON) and Dow AgroSciences LLC, a wholly-owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced today that the companies have reached a non-exclusive global option and licensing agreement on Dow AgroSciences’ EXZACT™ Precision Technology® Platform for research and commercial development of new crop solutions across Monsanto Company’s research portfolio.